|
|
Article: Avid Radiopharmaceuticals to Present at Oppenheimer 20th Annual Healthcare Conference on November 3rd.(Conference news)
- Article from:
- Nanotechnology Business Journal
- Article date:
- November 9, 2009
CopyrightCOPYRIGHT 2009 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Avid Radiopharmaceuticals, Inc., a leader in the development of products with the potential for earlier and more effective detection, diagnosis and monitoring of brain disorders, announced that Daniel M. Skovronsky, M.D., Ph.D., Founder and CEO, will present at the Oppenheimer 20th Annual Healthcare Conference on Tuesday, November 3, 2009 at 1:00pm ET in the Louis XVI Room at the Waldorf=Astoria in New York, NY.
Dr. Skovronsky will present an update on Phase III clinical trials and the timeline towards commercialization for the company's amyloid imaging compound 18F-AV-45 (AV-45), the most advanced F-18 compound in development for imaging amyloid plaque in the ...